HUP0202124A2 - Eljárás gyógyszerészetileg aktív fehérjék tisztítására kationcserélő kromatográfiával - Google Patents

Eljárás gyógyszerészetileg aktív fehérjék tisztítására kationcserélő kromatográfiával

Info

Publication number
HUP0202124A2
HUP0202124A2 HU0202124A HUP0202124A HUP0202124A2 HU P0202124 A2 HUP0202124 A2 HU P0202124A2 HU 0202124 A HU0202124 A HU 0202124A HU P0202124 A HUP0202124 A HU P0202124A HU P0202124 A2 HUP0202124 A2 HU P0202124A2
Authority
HU
Hungary
Prior art keywords
purification
exchange chromatography
active proteins
pharmacologically active
cationic exchange
Prior art date
Application number
HU0202124A
Other languages
English (en)
Inventor
Lucia Scapol
Giuseppe Claudio Viscomi
Original Assignee
Alfa Wassermann S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann S.P.A. filed Critical Alfa Wassermann S.P.A.
Publication of HU0202124D0 publication Critical patent/HU0202124D0/hu
Publication of HUP0202124A2 publication Critical patent/HUP0202124A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya eljárás gyógyszerészetileg aktív fehérjéktisztítására, ami szilárd mátrixon, valamint lúgosabb pH-n, azaz atisztításra kijelölt fehérje izoelektromos pontjánál (pI) magasabb pH-n végrehajtott kationcserélő kromatográfián alapul, mely pH-n a szóbanforgó fehérje még az ioncserélőn abszorbeálódik. Az ilyen eredményekeléréséhez a pufferoldatok pH értékét és a ionerősségét időről-időre atisztításra kijelölt adott gyógyszerészetileg aktív fehérjénekmegfelelően beállítják. Az eljárás főleg az interferon és az albuminfehérjék tisztítását célozza meg. Ó
HU0202124A 2001-07-06 2002-06-28 Eljárás gyógyszerészetileg aktív fehérjék tisztítására kationcserélő kromatográfiával HUP0202124A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001BO000426A ITBO20010426A1 (it) 2001-07-06 2001-07-06 Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico

Publications (2)

Publication Number Publication Date
HU0202124D0 HU0202124D0 (hu) 2002-09-28
HUP0202124A2 true HUP0202124A2 (hu) 2003-10-28

Family

ID=11439471

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202124A HUP0202124A2 (hu) 2001-07-06 2002-06-28 Eljárás gyógyszerészetileg aktív fehérjék tisztítására kationcserélő kromatográfiával

Country Status (27)

Country Link
US (1) US6866782B2 (hu)
EP (1) EP1273592B1 (hu)
JP (1) JP3940037B2 (hu)
KR (1) KR100771252B1 (hu)
CN (1) CN100484954C (hu)
AR (1) AR034663A1 (hu)
AT (1) ATE307824T1 (hu)
BG (1) BG65748B1 (hu)
BR (1) BR0202431A (hu)
CA (1) CA2388716C (hu)
CU (1) CU23149A3 (hu)
DE (1) DE60206847T2 (hu)
DK (1) DK1273592T3 (hu)
DZ (1) DZ3236A1 (hu)
EG (1) EG23150A (hu)
ES (1) ES2250544T3 (hu)
HR (1) HRP20020480B1 (hu)
HU (1) HUP0202124A2 (hu)
IT (1) ITBO20010426A1 (hu)
ME (1) MEP3408A (hu)
MX (1) MXPA02006303A (hu)
PL (1) PL209954B1 (hu)
RS (1) RS51512B (hu)
RU (1) RU2274471C2 (hu)
SI (1) SI1273592T1 (hu)
SK (1) SK287827B6 (hu)
UY (1) UY27354A1 (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790025B2 (en) 2003-05-16 2010-09-07 Cryobiophysica, Inc. External gradient chromatofocusing
EP1739089A4 (en) * 2004-03-30 2007-05-02 Hiroshi Yanagisawa PROCESS FOR DISINTER SEPARATION
US7943046B2 (en) * 2004-10-01 2011-05-17 Agilent Technologies, Inc Methods and systems for on-column protein delipidation
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US20100261275A1 (en) * 2007-12-10 2010-10-14 Yves Durocher Production of Recombinant Interferon Proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
CN101768601B (zh) * 2010-02-01 2013-08-07 山东泉港药业有限公司 一种重组人血白蛋白—干扰素α2b的生产方法
SG10201605397PA (en) * 2011-07-01 2016-08-30 Hoffmann La Roche Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides
US8921113B2 (en) 2012-12-21 2014-12-30 Dionex Corporation Buffer kit and method of generating a linear pH gradient
SG11201506775VA (en) * 2013-03-08 2015-09-29 Genzyme Corp Continuous purification of therapeutic proteins
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
EP3221450A1 (en) * 2014-11-18 2017-09-27 Unichem Laboratories Limited An improved process for the preparation of pharmacopoeial grade interferon alpha 2b
CN106496302B (zh) * 2015-09-08 2021-12-10 三生国健药业（上海）股份有限公司 一种用离子交换层析纯化蛋白质的方法
GB201517450D0 (en) * 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
JP2018536418A (ja) * 2015-12-09 2018-12-13 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 脱離条件下で発酵固体からタンパク質を精製する方法
GB2568936B (en) 2017-12-01 2019-12-25 Ford Global Tech Llc Liquid cooled injector
AU2019332764A1 (en) 2018-08-31 2021-05-06 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
US11022585B2 (en) 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
CN111138523A (zh) * 2019-12-10 2020-05-12 天津生机集团股份有限公司 一种从重组鸡干扰素α复性液中纯化制备重组鸡干扰素α的方法
CN113968900B (zh) * 2020-07-23 2023-07-25 中元汇吉生物技术股份有限公司 一种纯化C1q蛋白的方法
CN115918902A (zh) * 2022-12-19 2023-04-07 新疆农业科学院农业质量标准与检测技术研究所 一种通过微水波扩散重力法预处理葡萄脱水并获取高酚葡萄提取物的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US4732683A (en) * 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) * 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
US5486470A (en) * 1994-07-21 1996-01-23 Merck & Co., Inc. Purified herpes simplex virus protease and methods of purification
CA2157219C (en) 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
AU6884396A (en) * 1995-09-07 1997-03-27 Ppl Therapeutics (Scotland) Ltd Purification of alpha-1 proteinase inhibitor
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process

Also Published As

Publication number Publication date
SI1273592T1 (sl) 2006-02-28
JP2003096092A (ja) 2003-04-03
CN100484954C (zh) 2009-05-06
RU2002117383A (ru) 2004-01-27
MXPA02006303A (es) 2003-02-10
KR100771252B1 (ko) 2007-10-30
BG106768A (en) 2003-05-30
BR0202431A (pt) 2003-09-09
CA2388716A1 (en) 2003-01-06
EP1273592A2 (en) 2003-01-08
US20030010715A1 (en) 2003-01-16
DE60206847T2 (de) 2006-07-06
DK1273592T3 (da) 2006-01-02
CN1396176A (zh) 2003-02-12
CA2388716C (en) 2008-01-08
HRP20020480B1 (en) 2006-11-30
SK8592002A3 (en) 2003-01-09
EG23150A (en) 2004-05-31
EP1273592A3 (en) 2003-03-19
ITBO20010426A1 (it) 2003-01-06
ITBO20010426A0 (it) 2001-07-06
PL354769A1 (en) 2003-01-13
ATE307824T1 (de) 2005-11-15
SK287827B6 (sk) 2011-11-04
KR20030005005A (ko) 2003-01-15
DE60206847D1 (de) 2005-12-01
US6866782B2 (en) 2005-03-15
HU0202124D0 (hu) 2002-09-28
PL209954B1 (pl) 2011-11-30
RS51512B (sr) 2011-06-30
CU23149A3 (es) 2006-06-29
ES2250544T3 (es) 2006-04-16
RU2274471C2 (ru) 2006-04-20
HRP20020480A2 (en) 2003-02-28
DZ3236A1 (fr) 2005-04-20
BG65748B1 (bg) 2009-09-30
UY27354A1 (es) 2003-04-30
EP1273592B1 (en) 2005-10-26
MEP3408A (en) 2010-10-10
YU50502A (sh) 2005-09-19
JP3940037B2 (ja) 2007-07-04
AR034663A1 (es) 2004-03-03

Similar Documents

Publication Publication Date Title
HUP0202124A2 (hu) Eljárás gyógyszerészetileg aktív fehérjék tisztítására kationcserélő kromatográfiával
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
MEP3708A (en) Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
HUP0003401A2 (hu) Az aktivált protein C feldolgozásának javított eljárása
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
DK1075488T4 (da) Proteinoprensning ved ionbytningskromatografi
ATE234108T1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
DK0735818T3 (da) Makrofag-inflammatoriske proteiner MIP-3, Mip-4 og Mip-1gamma
TW200711657A (en) Pharmaceutical composition comprising botulinum toxin and recombinant human serum albumin
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
FI970579A0 (fi) Andenovirus, joka käsittää glutationiperoksidaasia koodittavan geenin
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
PT1062244E (pt) Metodos melhorados para produzir proteinas do factor viii
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
ATE554793T1 (de) Konjugat
ATE368740T1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
PL353349A1 (en) Method for isolating and purifying grass pollen allergens
IE840977L (en) Pharmaceutical preparations
YU48126B (sh) Postupak za pripremanje proteina plasmodium falciparum-a
AU2002236264A1 (en) Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid
WO2002055019A3 (en) Methods for ameliorating childhood infections
JPH022388A (ja) 新規なヒト顆粒球マクロファージコロニー刺激因子
WO2004058812A3 (en) Ribose-phosphate pyrophosphokinase polypeptides and structures
WO2001075050A3 (fr) Nouveau polypeptide, proteine humaine associee au transport vesiculaire 9, et polynucleotide codant pour ce polypeptide
RU93005154A (ru) Белки, фармацевтические композиции, нуклеиновые кислоты, векторы, системы вектор-хозяин, способ получения белка, способы модифицирования функции, способы лечения, способ трансфекции, способ переноса гена, способ измерения активности

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal